3-1. 지식재산권 & 노하우 - 산업체

비밀유지 계약서(지재권)

한국과학기술원(이하“KAIST”라 한다.)과             주식회사(이하“기업”이라 한다.)는 다음과 같이 비밀유지계약(이하 “본 계약”이라 한다.)을 체결한다.

제1조(목적)

본 계약은 “KAIST”의 출원(등록) 특허 및 그와 관련된 기술내용에 대해서 “기업”이 그 기술내용을 검증하고 상용화 가능성을 파악하기 위해 제공받거나 인지하게 되는 하기의 대상 출원(등록) 특허에 관한 “KAIST”의 특허 관련 비밀정보(미공개 특허 출원명세서의 내용 및 노하우 포함)를 보호하기 위한 것이다.

출원번호

출원일

발명의 명칭

제2조(용어의 정의)

본 계약에서 “비밀정보”라 함은 “기업”이 “KAIST”로부터 제공받는 정보 일체를 말하며, 정보제공 당시 “KAIST”가 “기업”에게 비밀정보임을 명확히 표시한 것을 말한다. 단, 다음 각 호의 경우에는 비밀정보에 포함되지 않는 것으로 본다.

1. 정보 제공 당시 “기업”이 이미 합법적으로 소유하고 있었던 정보인 경우

2. 정보 제공 당시 이미 공중에 공개된 정보인 경우

3. “기업”이 합법적으로 공중에 공개할 권리를 가진 제3자로부터 제공받은 정보인 경우

4. “KAIST"가 비밀유지의 의무를 부담시키지 않고 제공한 정보

제3조(비밀정보의 보호)

① “기업”은 “KAIST”로부터 제공받는 제2조의 비밀정보를 기술이전 및 기술사업화를 위한 내용분석의 목적 범위 내에서만 사용할 수 있으며, 비밀정보가 도난, 훼손, 멸실되거나 기타 제3자에게 유출되지 않도록 관리 책임을 다하여야 한다.

② “기업”은 “KAIST”로부터 제공받은 비밀정보를 “KAIST”의 사전 서면동의 없이 제3자에게 누설하거나 반출, 복사, 복제, 유출, 판매, 발표하는 등 일체의 공개 행위를 하여서는 아니된다.  또한, "KAIST"의 사전 서면승인을 얻은 경우도 "KAIST"와 제3자간의 비밀유지계약을 체결하여야 한다.

③ “기업”은 위 ①, ②의 의무사항을 위반했을 경우, 이에 따른 손해배상을 포함한 민형사상의 책임을 진다.

제4조(비밀정보의 반환)

① “기업”은 본 계약이 중지된 이후에는 “KAIST”로부터 제공받은 비밀정보를 “KAIST”에게 반환하거나 폐기하여야 한다.

② “KAIST"가 언제라도 서면에 의하여 제공된 비밀정보의 반환을 "기업”에게 요구하는 경우에는 지체없이 "KAIST"에게 비밀정보의 원본, 사본 및 비밀정보를 이용하여 생성한 서면 자료, 기술자료, 데이터 정보 등을 “KAIST"의 선택에 따라 반환하거나 폐기하여야 하며, 폐기한 경우에는 그 때로부터 10일 내에 ”KAIST"에게 서면에 의한 확인서를 제출하여야 한다.

제5조(계약기간)

본 계약의 유효기간 및 “기업”의 비밀유지 의무는 본 계약 체결일로부터 3년간으로 한다.

제6조(양도금지)

양 당사자는 상대방의 사전 서면동의 없이 본 계약서의 권리 및 의무의 전부 또는 일부나 계약상의 지위를 제3자에게 양도하거나 담보로  제공할 수 없으며, 본 계약은 양 당사자의 양수인 또는 승계인에게도 구속력을 가진다.

제7조(보증)

“KAIST"는 본 계약에 의해 ”기업“에게 제공한 비밀정보와 관련하여 본 계약의 목적 이외에 "기업”에게 어떠한 권리도 부여하지 않으며, 제공된 비밀정보의 내용에 대하여 어떠한 보증도 하지 않는다. 또한, 제공된 각 비밀정보와 관련하여 발생하는 분쟁, 사고, 손해 및 기타 법률적 문제에 대하여 그 비밀정보를 제공한 ”KAIST"는 어떠한 책임도 지지 아니한다.

제8조(비밀정보에 대한 권리 귀속)

① ”기업“에게 제공한 비밀정보에 대한 소유권 및 지식재산권 등 일체의 권리는 ”KAIST"에게 있으며, 본 계약이 “기업”에게 이러한 권리를 양도하거나 권리의 사용을 허락하는 것으로 해석되지 아니한다.

② 비밀정보를 통하여 특허출원 등이 가능할 경우 특허를 받을 권리는 “KAIST"에게 있으며, "기업”이 “KAIST"로부터 제공받은 비밀정보를 개량 기타 지적활동을 통하여 새로운 기술, 정보 및 지식재산권을 형성하고자 하는 경우 "KAIST"의 사전 서면동의를 얻어야 한다.

제9조(손해배상)

① “기업”은 “KAIST"의 서면동의 없이 비밀정보를 고의 또는 과실로 제3자에게 공개, 제공 또는 누설한 경우 등 본 계약을 위반함으로 인하여 "KAIST"가 입은 손해를 배상하여야 한다.

② "기업“이 본 계약상의 의무를 위반하거나 위반할 우려가 있는 경우, ”KAIST"는 자신이 제공한 비밀정보를 보호하기 위하여 원상회복 및 반환, 정보사용, 기타 침해행위의 금지 또는 예방 등 적절한 법적 조치를 취할 수 있으며, "기업“은 이에 대한 모든 민.형사상의 책임을 진다.

제10조(구속력)

① 본 계약에서 명시한 경우를 제외하고는 본 계약의 이행 또는 비밀정보의 제공이 어떠한 경우에도 “KAIST"가 자신의 현재 또는 장래의 영업비밀, 상표권, 특허권 기타의 권리에 대한 실시권, 사용권 등의 권리를 "기업”에게 부여하는 것으로 해석되지 아니한다.

② 본 계약은 어떠한 경우에도 양 당사자간에 어떠한 확정적인 후속 계약의 체결, 상품의 판매나 구입, 상호 지출한 비용에 대한 보상 등에 관한 내용을 암시하거나 이를 강제하지 아니하며, 기타 각 당사자가 제3자와 어떠한 거래 또는 계약 관계에 진입하는 것을 제한하지 아니한다.

제11조(분쟁해결 등)

① 본 계약에 명시되어 있지 아니한 사항이나 본 계약의 해석에 관하여 양 당사자 간에 다툼이 있는 경우, 관계법령 및 일반적 상관례에 따라 상호 호혜적인 입장에서 협의하여 결정한다.

② 본 계약은 대한민국 법령의 적용을 받으며, 본 계약과 관련하여 양 당사자간에 분쟁이 발생한 경우, 양 당사자는 신의성실 원칙에 입각하여 이를 해결하도록 노력하며, 상호간에 우호적으로 분쟁이 해결되지 않을 경우 대한상사중재원의 중재결정에 따르도록 한다.

제12조(계약의 효력)

본 계약은 본 계약 체결 이전에 이루어진 양 당사자 간의 구두 또는 서면상의 양해 또는 합의에 우선하며, 양 당사자의 서면합의에 의하여서만 변경될 수 있다. 또한, 본 계약 상의 권리에 대한 불행사는 그 권리의 포기로 간주되지 아니한다.

위와 같이 계약이 체결되었음을 증명하기 위하여 “기업”과 “KAIST”는 본 계약서 2부를 작성하여 각 기명 날인한 후 각 1부씩 보관한다.

20    년    월      일

“KAIST”

대전광역시 유성구 과학로 291

한국과학기술원

총  장   강 성 모     (인)

담당자   ○ ○ ○    (인)

연락처   042-350-****

“기업”

주  소:

○○○○○○○주식회사

대표이사   ○ ○ ○    (인)

담당자     ○ ○ ○    (인)

연락처     02-

<별첨> 법인등기부등본, 법인인감증명서

3-2. KNOW-HOW - 산업체

비밀유지 계약서(노하우)

주식회사○○○(이하“○○”이라 한다)와 한국과학기술원(이하 “KAIST”라 한다)은 다음과 같이 비밀유지계약(이하 “본계약”이라 한다)을 체결한다.

제1조 (목적)

본 계약은‘                                  의 공동개발’ (이하“프로젝트”라한다)를 위하여 “○○” 또는 “KAIST”가 상대방에게 제공하는 관련 비밀정보를 보호하기 위하여 필요한 사항을 규정함에 그 목적이 있다.

제2조 (대표 또는 대리인)

본 계약 상 비밀제공에 관한 조정 및 협의를 하고, 비밀정보를 수령하는 데 있어서 양당사자를 대표 또는 대리하는 자는 다음과 같다.

○ ○ :  ○○○

KAIST :  ○○○교수

제3조 (비밀정보)

본 계약에서 “비밀정보”란 “프로젝트”와 관련하여 양당사자가 “프로젝트”에 관한 업 무진행 과정에서 어느 일방당사자(“정보제공자”)가 상대당사자 (“정보수령자”) 에게 서면, 구두, 전자적 방법에 의한 전송 또는 기타의 방법으로 제공하는 모든 노하우, 기술, 공정, 도면, 설계, 디자인, 코드, 실험, 시제품, 스펙, 데이터, 프로그램, 명세 서, 아이디어, 사업정보, 경영정보 등 일체의 정보로서 유∙무형의 여부 및 그 기록 형태 일체를 말한다.

“정보제공자”가 “정보수령자”에게 서면 제출, 메일 전송, 물품인도 등 유형적인 형 태로 “비밀정보”를 제공 할 경우, 그 제공 당시 “비밀” 또는 이와 유사한 표식에 의 하여 그것이 “비밀정보”에 해당됨을 명확히 인지할 수 있도록 표시하여야 한다.

“정보제공자”가 “정보수령자”에게 유형적인 형태이외의 구두, 영상에 의한 방법 또는 시설, 장비, 샘플 기타 품목을 관찰하거나 조사하게 하는 방법에 의하여 “비밀정보” 를 제공할 경우, 그 제공당시 “정보수령자”에게 그것이 “비밀정보”임을 고지하고, 고 지한 때로부터 30일내에 공개범위, 공개일자, 공개장소 및 공개대상자 등이 명시된 요약본을 서면제출, 이메일 전송 등의 유형적인 기록형태로 “정보수령자”에게 제공 하여야 한다.

제4조 (비밀정보의 보호)

“정보수령자”는 “정보제공자”의 사전 서면승인이 없는 한 “비밀정보”를 “프로젝트”  이외의 다른 목적이나 용도로 사용할 수 없으며, “프로젝트”와 관련하여  사용할 경우에도 필요한 업무수행의 범위를 초과하여 “비밀정보”를 임의로 복제, 수정, 저장, 변형 또는 분석하는 등의 행위를 할 수 없다.

“정보수령자”는 제2조의 책임자 및 그 지도를 받아 “프로젝트”를 위하여 “비밀정 보”에 접근할 필요가 있는 “정보수령자” 소속인원으로서 본 계약에 준하는 내용을 담은 ‘비밀유지서약서’를 제출한 인원외에는 “정보제공자”의 사전 서면승인 없이는 어떠한 제3자에게도 “비밀정보”를 제공할 수 없다. 또한, “정보제공자”의 사전 서면 승인을 얻은 경우도 “정보제공자”와 제3자간 의 ‘비밀유지계약’을 체결하여야 한다.

“정보수령자”는 취득한 “비밀정보”를 자신의 “비밀정보”를 보호 및 유지하는 차원 에서 주의 관리하여야 한다.

“정보수령자”는 “비밀정보”의 외부로의 누설 또는 “비밀정보”의 대내외적 오사용 등 침해사실이 발견된 경우 즉시 “정보제공자”에게 서면으로 그 사실을 통보하고, “정보 제공자”가 요구하는 적절한 조치를 취하여야 한다.

“비밀정보”가 물질 또는 샘플인 경우 “정보수령자”는 “정보제공자”의 사전 서면동의 없이reverse engineering을 할 수 없다.

“○○”과 “KAIST”는 상대방의 사전 서면동의 없이 본 계약(“프로젝트”에 관한 계약 포함)을 체결한 사실 및 그 내용을 제3자에게 제공하거나 누설할 수 없다.

제5조 (계약기간, 비밀유지기간)

본 계약은 20    년     월     일부터  20    년    월      까지 유효하다.

“정보수령자”의 “비밀정보”에 대한 보호의무는 본 계약이 유효하게 존속하는 기간 및 그 기간경과 후에도 2년간 유효하다.

제2항에도 불구하고 그 성질상 계속하여 효력을 유지하여야 할 조항은 본 계약이 해 지되거나 계약기간 만료 후에도 계속하여 유효하다.

제6조 (“비밀정보”의 표시)

“비밀정보” 수령자의 비밀보호의무는 제3조에 규정한 “비밀정보” 중 다음 각 호에 해당 되는 “비밀정보”에 한하여 적용된다.

1.“비밀정보” 제공당시“ 대외비” 등의 표시로 “비밀정보”임을 표시한 것

2.“비밀정보” 제공당시 비밀임을 나타내는 표시는 되지 않았지만, 비밀로서 취급되 어지고, 제공 후 15일 이내에 “비밀정보”임을 표시하는 문서를 “정보수령자” 에게 통지한 것

제7조 (법원, 정부기관에 대한 제공)

“정보수령자”는 법원 또는 정부기관으로부터 “비밀정보”의 제공을 요구받은 경우, 즉시 “정보제공자”에게 그 사실을 서면통지하여 “정보제공자”가 적시에 적절한 보호 및 대응조치를 취할 수 있도록하여야 한다.

“정보수령자”는 법원 또는 정부기관에게 “비밀정보”를 제공하여야 할 상황이 발생한 경우 i)법원 또는 정부기관이 “비밀정보”의 비공개 필요성에 대하여 납득하도록 충 분히 노력하여야 하고, ii)이를 제공하여야 할 경우라도 법령에 따라 요구되는 필요한 최소한도내에서 제공하여야 하며, iii)제공된 “비밀정보”가 법원 또는 정부기관에 의 하여 비밀로 취급되도록 노력하여야 하고, iv)그와 같은 “비밀정보”를 보호하기 위한 “정보제공자”의 일체의 행위에 최대한 협조하여야 한다.

제8조 (“비밀정보”의 제외 사유)

다음 각 호에 해당하는 정보가 객관적인 증거에 의하여 입증되는 경우에는 “비밀정보”에 해당하지 아니한 것으로 본다.

“비밀정보”의 제공 이전에 이미 일반 공중에게 공개되거나 계약기간 중 “비밀정보”를 수령한 일방의 귀책사유 없이 일반 공중에게 공개된 정보

어느 일방이 본 계약의 체결이전 또는 계약기간 중에 제3자로부터 적법하게 제공 받아 보유하고 있는정보

“정보제공자”가 비밀유지 의무를 부담시키지 않고 제공한 정보

제9조 (보증)

“정보제공자”는 “비밀정보”의 정확성 및 완전성이나 “프로젝트”에 대한 적합성 및 제3자의 권리침해 여부에 대한어떠한 보증도 하지 않는다.

“정보제공자”는 본 계약에 의해 “정보수령자”에게 제공한 “비밀정보”와 관련하여, 본 계약의 목적 이외에 “정보수령자”에게 어떠한 권리도 부여하지 않으며, 제공된 “비밀정보”의 내용에 대하여 어떠한 보증도 하지 않는다. 또한, 제공된 각 “비밀정보”와 관련하여 발생하는 분쟁, 사고, 손해 및 기타 법률적 문제에 대하여 그 “비밀정보”의 제공 당사자는 어떠한 책임도 지지 아니한다.

제10조 (“비밀정보”에 대한 권리 귀속)

“비밀정보”는 이를 제공한 자에게 소유권 및 지식재산권 등 일체의 권리가 있으며, 본 계약이 상대방에게 이러한 권리를 양도하거나 권리의 사용을 허락하는 것으로 해석되지 아니한다.

“비밀정보”를 통하여 특허출원 등이 가능할 경우 특허를 받을 권리는 “정보제공자” 에게 있으며, “정보수령자”가 상대방으로부터 제공받은 “비밀정보”를 개량 기타 지적 활동을 통하여 새로운 기술, 정보 및 지식재산권을 형성하고자 하는 경우 상대방의 사전 서면동의를 얻어야 한다.

제11조 (“비밀정보”의 반환)

“정보수령자”는 i)계약기간의 만료 등의 사유로 본 계약이 종료된 경우, ii) “정보제공 자”가 언제라도 서면에 의하여 제공된 비밀정보의 반환을 요구하는 경우에는 지체없이 “정보제공자”에게 “비밀정보”의 원본, 사본 및 “비밀정보”를 이용하여 생성한 서면, 자 료, 데이터 등을 “정보제공자”의 선택에 따라 반환하거나 폐기하여야 하며, 폐기한 경우 에는 그 때로부터 10일내에 “정보제공자”에게 서면에 의한 확인서를 제출하여야 한다.

제12조 (손해배상)

“정보수령자”는 “정보제공자”의 서면동의 없이 “비밀정보”를 고의 또는 과실로 제3자에게 공개, 제공 또는 누설한 경우 등 본 계약을 위반함으로 인하여 “정보 제 공자”가 입은 손해를 배상하여야 한다.

“정보수령자”가 본 계약 상의 의무를 위반하거나 위반할 우려가 있는 경우, “정보제공자”는 자신이 제공한 “비밀정보”를 보호하기 위하여 원상 회복 및 반환, 정보사용, 기타 침해행위의 금지 또는 예방 등 적절한 법적 조치를 취할 수 있으며, 귀책있는 계약당사자는 이에 대한 모든 민.형사상 책임을 진다.

전 항의 법적 조치 행위로 인하여 귀책있는 “정보제공자”의 상대방은 계약 혹은 법률에 근거하여 행사할 수 있는 다른 권리 행사를 제한받지 아니하며, 만일 귀책있는 “정보제공자”의 상대방에게 손해가 발생하는 경우 귀책있는 “정보제공자”는 상대방에게 발생한 손해 전부를 즉시 배상하여야 한다.

제13조 (구속력)

본 계약에서명시한경우를제외하고는본 계약의 이행 또는 “비밀정보”의 제공이 어떠 한 경우에도 “정보제공자”가 자신의 현재 또는 장래의 영업비밀,  상표권, 특허권 기 타의 권리에 대한 실시권, 사용권 등의 권리를 “정보수령자” 에게 부여하는 것으로 해석되지 아니한다.

본 계약은 어떠한 경우에도 양당사자간에 어떠한 확정적인 후속 계약의 체결, 상품의 판매나 구입, 상호 지출한 비용에 대한 보상 등에 관한 내용을 암시하거나 이를 강제 하지 아니하며, 기타 각 당사자가 제3자와 어떠한 거래 또는 계약관계에 진입하는 것 을 제한하지 아니한다.

제14조 (양도 금지)

각 당사자는 상대방의 사전 서면동의 없이 본 계약에 의하여 발생하는 권리, 의무의 전 부 또는 일부를 제3자에게 양도, 위임, 위탁, 담보의 목적으로 제공하거나 기타 어떠한 처분행위도 할 수 없다.

제15조 (계약의 효력)

본 계약은 계약 체결이전에 이루어진 당사자 간의 구두 또는 서면 상의 양해 또는 합의 에 우선하며, 양당사자의 서면합의에 의하여만 변경될 수 있다. 또한, 본 계약 상의 권리 불행사는그 권리의 포기로 간주되지 아니한다.

제16조 (관할법원)

본 계약에 명시되지 아니한 사항 및 계약의 해석 상 이의가 있을 경우에는 쌍방의 합의 로 결정하며, 본 계약과 관련하여 발생하는 분쟁은 사단법인대한상사중재원의 중재 결정 에 따르도록 한다.

위와 같이 계약이 체결되었음을 증명하기 위하여  “○○” 과 “ KAIST”는 본 계약서 2부 를 작성하여 각각 기명 날인한 후 각 1부씩 보관한다.

첨부. “○○”, “KAIST”의 법인인감증명서, 법인등기부등본, 사업자등록증 사본, 각 1부

20    년     월       일

“○○”	“KAIST”

주식회사○○○	한국과학기술원

주소:	대전광역시 유성구 대학로 291

대표이사               (인)             총장   강  성  모       (인)

3-3. 기술거래 중개

CONFIDENTIALlTY AND

NON DISCLOSURE AGREEMENT

THIS AGREEMENT, dated on          of May2013, by and between             having office in ___________              ,and Korea Advanced Institute ofScience and Technology(“KAIST”)having offices in 335 Gwahangno, Yuseong-gu, Daejeon, South Koreaunder brokeraging of P&IB  having offices in                                                                               .

The primary contact(s) for disclosing or receiving confidential information for these parties are as follows:

For            :  Name:                            Email:

Departmant:

For KAIST:  Name:                                  Email:

Departmant:

For            (Broker):  Name:                     Email:

Department:

KAIST has Transparent Electrode Formed Nanostructure Pattern and Method for Preparing the Sameas patents listed in the table below (the “Technology")and       wishes to evaluate the same for possible commercialization;

List of technologies

No

Application

State

Applicant

Application Number

Title of Invention

1

2

3

4

5

Whereas, the parties recognize that in order to accomplish these purposes, it may be necessary or appropriate for one party to disclose to the other, information or technology which is considered by the disclosing party to constitute its confidential or proprietary business secrets which include but are not limited to KAIST’s Technology;

In consideration of each party making confidential information available to the other party, the parties hereby agree as follows:

1. ConfidentialInformation.  (a)The recipient (“Receiving Party”) of the Confidential Information shall not disclose any of the Confidential Information provided to it by the other party (the “Disclosing Party”) to others and may disclose such Confidential Information to only its officers or employees who reasonably require knowledge of such Confidential Information for the limited purpose of evaluating the licensing potential of the Confidential Information and who have a secrecy obligation to Receiving Party, in which case such officers and/or employees shall only use such Confidential Information for such limited purpose. Receiving Party acknowledges that (i) such Confidential Information constitutes a valuable trade secret of the other party and (ii) any unauthorized disclosure or use of such Confidential Information by Receiving Party will cause irreparable harm to the other party.  Receiving Party shall use or allow such Confidential Information to be used only in a manner consistent with the terms and conditions of this Agreement.

(b)All written information and all items shall be labeled with the Disclosing Party's name and with the words "Confidential", "Proprietary", and /or "Private".

(c)All visual or oral information shall be presumed to be private, proprietary of confidential at the time of disclosure to recipient. Such presumption shall expire thirty (30)days after disclosure to recipient unless, at the time of disclosure or before expiration of the thirty (30)days period following disclosure, the disclosing party expressly identifies such visual or oral information as private, proprietary or confidential by written or oral statement.

2. Exceptions.  Confidential Information disclosed shall remain confidential unless and to the extent that:

(a)the Confidential Information is, or becomes, in the public domain;

(b)Receiving Party receives the Confidential Information from a third party not privy to this Agreement as a matter of right and not in violation of the confidential relationship created under this Agreement nor in violation of any obligation to the Disclosing Party;

(c) the Disclosing Party approves release of the Confidential Information by written authorization.

(d) Receiving Party can demonstrate by written record that Confidential Information was previously known to it.

(e) Receiving Party can demonstrate that the Confidential Information was independently developed by the Receiving Party or its employees having no knowledge of the Confidential Information supplied by the Disclosing Party.

The exceptions set forth above shall apply only in the event and to the extent that Receiving Party provides the Disclosing Party with written documentation or records of the Confidential Information in substantially the same degree of specificity as the disclosure of the Confidential Information is made hereunder.

3. Disclosure in Judicial or Administrative Proceeding   If Receiving Party is required to produce the Confidential Information by law, governmental proceeding or court order, Receiving Party may disclose such Confidential Information without liability hereunder; provided, however, before producing any Confidential Information, Receiving Party shall notify the Disclosing Party promptly of any such proceeding or court order in order to provide the Disclosing Party with a reasonable amount of time so that the Disclosing Party may seek an appropriate protective order or other appropriate remedy and/or waive the Receiving Party’s compliance with the provisions of this Agreement.  In the event that such protective order or other remedy is not obtained, or that the Disclosing Party grants a waiver hereunder, the Receiving Party may furnish that portion of the Confidential Information which, in the opinion of the Receiving Party’s counsel, it is legally required by applicable law to disclose and will reasonably cooperate with the Disclosing Party’s efforts, at the Disclosing Party’s expense, to obtain confidential treatment of the Confidential Information so furnished.

4. Announcements.    Except as may be necessary, in the opinion of counsel, to comply with the requirements of any law, governmental regulation or order, or the requirements of any stock exchange on which shares of the party hereto making any announcement or statement or issuing any release may be listed, at no time shall either party, without the prior written consent of the other party hereto, make any announcement, press release or any statement to any third party, which announcement, press release or statement relates to or refers to any of the specific matters discussed between them or which might identify (either directly or indirectly) the other party hereto as being involved in such discussions.

5. Return of Material.   At any time upon the Disclosing Party’s request, Receiving Party shall immediately return all Confidential Information provided by the Disclosing Party and destroy all information developed therefore from which the Confidential Information is revealed or could be ascertained.  Upon returning Confidential Information, an officer of Receiving Party shall certify that Receiving Party has complied with the provisions of this paragraph.  Provided, however, Receiving Party may retain one (1) copy of the Confidential Information (but not including any product samples) solely for archival purposes of complying with this Agreement.

6. Injunction.  In the event of a breach or a threatened breach of the terms of this Agreement, the Disclosing Party shall be entitled to an injunction restraining Receiving Party, its officers or employees about to commit any breach of this Agreement or who have committed a breach of this Agreement from continuing the same, without showing or proving any actual damage sustained by the Disclosing Party.  Receiving Party acknowledges that this Agreement is made for the benefit of Receiving Party as well as for the benefit of the Disclosing Party and that money damages are inadequate to compensate the Disclosing Party for any breach of this Agreement.  Nevertheless, in the event of such breach, the Disclosing Party shall, in addition to this injunctive relief, be entitled to all other remedies provided for by law including, but not limited to, an award of damages.

7. Officers and Employees.  Receiving Party shall be completely responsible for maintaining the secrecy and confidentiality of the Confidential Information conveyed to Receiving Party in accordance with the terms of this Agreement and shall be responsible for the actions and activities of all of Receiving Party's officers and employees working with or otherwise having access to the Confidential Information.

8. No License     The Receiving Party acknowledges that the Disclosing Party (or any third party entrusting its own confidential information to the Disclosing Party) claims ownership of the Confidential Information disclosed by the Disclosing Party and all patent, copyrights, trademark, trade secret, and other intellectual property rights in, or arising from, such Confidential Information.  No option, license, or conveyance of such rights to the Receiving Party is granted or implied under this Agreement.  If any such rights are to be granted to the Receiving Party, such grant shall be expressly set forth in a separate written instrument.  Neither party shall be obligated to engage in the commercialization of the concepts, projects or information exchanged hereunder.

9. Term  The obligations and restrictions of Receiving Party under this Agreement shall continue for a period of five (5) years from the date of the last disclosure contemplated in this Agreement.

10. Notice  Any notices to be given under this Agreement shall be in writing and addressed to the parties as shown below. Notices shall be delivered by certified or registered first class mail (air mail if not domestic) or by commercial courier service and shall be deemed to have been given or made as of the date received.

FOR  KAIST:

FOR  COMPANY:

Office of University-Industry Cooperation,

291 Kwahackro, Yuseong-gu,

Daejeon 305-701, Republic of Korea

_______________________________________

_______________________________________

_______________________________________

11. Governing Law.    All disputes arising out of or related to this Agreement, or the performance, enforcement, breach or termination hereof, and any remedies relating thereto, shall be construed, governed, interpreted and applied in accordance with the laws of Korea,except that questions affecting the construction and effect of any patent shall be determined by the law of the country in which the patent shall have been granted.  Furthermore the parties hereto agree that venue for resolution of any such dispute shall be in Korea.

12. Entire Agreement.   This Agreement shall supersede and prevail over any other prior arrangements, either oral or written, as to the Confidential Information received under this Agreement.  This Agreement constitutes the entire agreement between the parties relative to this subject matter and shall not be amended, except in a writing signed by both parties.

IN WITNESS WHEREOF, the authorized representatives of the parties have duly executed this Agreement as of the date first above written.

Company

Signature:

Korea Advanced Institute of Science and Technology (KAIST)

Signature:

By:

President,

By: Jung Meon Bae

Dean of University-Industry Cooperation

Broker

Signature:

By:

President,

3-4. IT 분야

MUTUAL NON-DISCLOSURE AGREEMENT

This agreement (the "Agreement"), effective as of the date last signed (the “Effective Date”), is entered into by and between The Korea Advanced Institute of Science and Technology (KAIST), an institution organized and existing under the laws of the Republic of Korea located at 291 Daehak-ro, Yuseong-gu, Daejeon 305-701, Republic of Korea("KAIST"), and, __________, a            corporation having its principal place of business at ____________________. ("Party"). The foregoing Parties may be referred to herein individually as a “Party” and together as the “Parties”.

1. Confidential Information.  "Confidential Information" shall mean (i) all information or material labeled "Confidential" or "Proprietary" regarding techniques, drawings, models, inventions, technical know-how, processes, algorithms, software programs, software source documents, application programmer's interface ("API") and formulae related to the current and proposed products and services of each of the Parties; (ii) all informationor material labeled "Confidential" or "Proprietary", concerning research and development, that is disclosed by the disclosing Party ("Discloser") to the receiving Party ("Recipient"); (iii) all information or material labeled "Confidential" or "Proprietary" relating to actual and potential customers, financial data and information, business plans, marketing materials and strategies.If a Party discloses Confidential Information visually, orally or in any other manner incapable of physical marking to the other Party, Discloser shall inform Recipient that such information is confidential and proprietary at the time of the disclosure, shall reduce the Confidential Information to writing and label it as such, and send the writing to Recipient within thirty (30) days of the disclosure. Except as otherwise indicated in this Agreement, the term Discloser and Recipient further includes all Affiliates of such Parties.  An Affiliate means any person, partnership, joint venture, corporation or other form of enterprise, domestic or foreign, including subsidiaries that directly or indirectly control, are controlled by, or are under common control with a Party.

2. Nondisclosure Obligations.  Each of the Parties agrees that it will not disclose or permit the disclosure of any Confidential Information of the other Party to any third Party.  Recipient may disclose Confidential Information only to its employees, advisors, agents,and consultants (“Representatives”)on a need to know basis and who are under written or legal obligations of confidentiality.  Furthermore, the existence of any business negotiations, discussions, or agreements between the Parties shall not be released to any form of public media without prior written approval of both Parties, except as required by law.  Each of the Parties agrees that it shall treat all Confidential Information of the other Party with the same degree of care as it accords to its own Confidential Information, and each of the Parties represents that it exercises at least reasonable care to protect its own Confidential Information. Eachof the Parties shall have the right to refuse to accept the disclosure of any Confidential Information, and neither Party shall be obligated to disclose to the other Party any particular Confidential Information.

3. Exclusions from Confidential Information.   Confidential Information shall not include information which:  (i) was in the public domain at or subsequent to the time it was communicated to Recipient by Discloser through no fault of Recipient; (ii)  was rightfully in Recipient's possession free of any obligation of confidence at or subsequent to the time it was communicated to Recipient by Discloser; (iii) was developed by employees or agents of Recipient independently of and without use of any Confidential Information of the other Party; or (iv) was communicated by Discloser to an unaffiliated third Party free of any obligation of confidence.  A disclosure of Confidential Information (a) in response to a valid order by a court or other governmental body, (b) otherwise required by law, or (c) necessary to establish the rights of either Party under this Agreement, shall not be considered to be a breach of this Agreement or a waiver of confidentiality for other purposes; provided, however, that Recipient shall provide prompt written notice thereof to enable Discloser to seek a protective order or otherwise prevent such disclosure.

4. Use of Confidential Information.  The Parties anticipate exchanging certain technical and business information for the limited purpose of engaging in business discussions relating to the evaluation of technologies, potential business relationship between the Parties and the sale and/or license of patents, patent applications, or inventions by KAIST. Recipient agrees to use any Confidential Information disclosed by Discloser solely for this stated purposes and not for any other purpose.  The Recipient shall not reverse engineer, disassemble or decompile any products, prototypes, software or other tangible objects which embody the Confidential Information disclosed by the Discloser and which are provided to the Recipient.

5. Term.  This Agreement shall be effective from the Effective Date and shall continue for a period of three(3) years.  Either Party may terminate this Agreement without cause upon thirty (30) days advance written notice to the other Party.Each Party's obligations under Paragraph 2 with respect to Confidential Information of the other Party shall survive any such expiration or termination.

6. Return of Information.  All Discloser Confidential Information, copies and summaries thereof shall be returned by the Recipient to the Discloser within ten (10) days of Discloser's request.  At Discloser's option, Confidential Information, including all copies, may instead be destroyed by Recipient provided an officer of Recipient certifies such destruction in writing to Discloser within five (5) days of Discloser’s instructions to Recipient.

7. No Assignment.  Neither Party will assign or transfer any rights or obligations under this Agreement without the prior written consent of the other Party.

8. No Title, License, No Warranty.  Title and right to possess Confidential Information shall remain in the Disclosing Party. No License is granted to either Party under any patents, copyrights, mask work rights, trademarks or other proprietary rights of the other. All information provided herein is “AS IS” and without warranty.

9. Governing Law.  This Agreement will be governed by the laws of the Republic of Korea, without giving effect to its conflicts of law principles. Any dispute, controversy or difference which may arise between the Parties hereto out of or in relation to or in connection with this Agreementshall be submitted to a courtof the Republic of Korea.

10. Waiver.  The waiver by either Party of a breach of any provision hereof shall not be taken or held to be a waiver of the provision itself.

11. Injunctive Relief.  A breach of any of the promises or agreements contained herein will result in irreparable and continuing damage to the non-breaching Party for which there will be no adequate remedy at law, and the non-breaching Party shall be entitled to seek injunctive relief and/or a decree for specific performance, and such other relief as may be proper (including monetary damages if appropriate).

12. Entire Agreement.  This Agreement states the entire agreement of the Parties regarding its subject matter.  It supersedes, and its terms govern, all prior proposals, agreements, or other communications between the Parties, oral or written, regarding such subject matter. This Agreement shall not be modified except by a subsequently dated written amendment signed on behalf of the Parties.

13. Severability.  If any provision of this Agreement should be held to be invalid in any way or unenforceable, it shall be severed and the remaining provisions shall not in any way be affected or impaired.  This Agreement shall be construed so as to most nearly give effect to the intent of the Parties as originally executed.

14. Counterparts.  This Agreement may be executed in counterparts, each of which shall be deemed an original Agreement for all purposes and which collectively shall constitute one and the same Agreement.  A facsimile,PDF or other electronic copy of any such executed counterpart shall be deemed an executed original.

The authorized representatives of the Parties have executed this Agreement as of the last date indicated below (the “Effective Date”).

KAIST(The Korea Advanced Institute of Science and Technology)

Party:

By:

By:

Name:

Name:

Title:

Date:

Title:

Date:

3-5. 바이오분야

MUTUAL NON-DISCLOSURE AGREEMENT

This agreement (the "Agreement"), effective as of the date last signed (the “Effective Date”), is entered into by and between The Korea Advanced Institute of Science and Technology (KAIST), an institution organized and existing under the laws of the Republic of Korea located at 291 Daehak-ro, Yuseong-gu, Daejeon 305-701, Republic of Korea on behalf of itself and its Affiliates("KAIST"), and, a            corporation having its principal place of business at ____________________. ("Party"). The foregoing Parties may be referred to herein individually as a “Party” and together as the “Parties”.

1. Confidential Information.  "Confidential Information" shall mean confidential or proprietary information that is disclosed by the disclosing Party ("Discloser") to the receiving Party ("Recipient") that is: disclosed orally, visually or in writing and is clearly marked or identified as proprietary or confidential at the time of disclosure; (b) disclosed under conditions or is of such a nature that would reasonably be deemed confidential or proprietary by the Discloser; or (c) acquired while accessing a Party’s site or facility.Confidential Information includes, without limitation, all information relating to actual and potential customers, financial data and information, business plans, marketing materials and strategies,  suppliers, markets, contracts, prices, products, personnel, strategies, policies, systems, procedures, technologies, know-how, data, processes, inventions, research, developments, formulations, applications, methods of manufacture and any other proprietary information of either Party or any of its Affiliates. An Affiliate means any person, partnership, joint venture, corporation or other form of enterprise, domestic or foreign, including subsidiaries that directly or indirectly control, are controlled by, or are under common control with a Party. For purposes of this definition, “control” (including with correlative meaning, the terms “controlled by” and “under common control with”) shall be presumed to exist if one of the following conditions is met:  (a) in the case of corporate entities, direct or indirect ownership of at least fifty percent (50%) of the stock or shares having the right to vote for the election of directors of such Party or any direct or indirect parent of such Party, and (b) in the case of non-corporate entities, direct or indirect ownership of at least fifty percent (50%) of the equity interest with the power to direct the management and policies of such non-corporate entities.

2. Nondisclosure Obligations.  Each of the Parties agrees that it will not disclose or permit the disclosure of any Confidential Information of the other Party to any third Party.  Recipient may disclose Confidential Information only to its employees, advisors, agents,consultants, affiliates(“Representatives”)on a need to know basis and who are under written or legal obligations of confidentiality at least at strict as those contained in this Agreement.  Each Party will be responsible for any breach of this Agreement by its respective Representatives. Furthermore, the existence of any business negotiations, discussions, or agreements between the Parties shall not be released to any form of public media without prior written approval of both Parties, except as required by law.  Each of the Parties agrees that it shall treat all Confidential Information of the other Party with the same degree of care as it accords to its own Confidential Information, and each of the Parties represents that it exercises at least reasonable care to protect its own Confidential Information. Eachof the Parties shall have the right to refuse to accept the disclosure of any Confidential Information, and neither Party shall be obligated to disclose to the other Party any particular Confidential Information. If Recipient has knowledge of the use or disclosure of Confidential Information received from Discloser in a manner that is not permitted under this Agreement, Recipient will give Discloser prompt written notice of the non-complying use or disclosure and will reasonably cooperate with Discloser to regain possession of any Confidential Information improperly delivered and prevent the further unauthorized disclosure or use of that Confidential Information.

3. Exclusions from Confidential Information.  Confidential Information shall not include information which Recipient can prove:  (i) was in the public domain at or subsequent to the time it was communicated to Recipient by Discloser through no fault of Recipient; (ii)  was rightfully in Recipient's possession free of any obligation of confidence at or subsequent to the time it was communicated to Recipient by Discloser and was not acquired directly or indirectly from the Discloser; (iii) was developed by employees or agents of Recipient independently of and without use of any Confidential Information of the other Party; or (iv) was communicated by Discloser to an unaffiliated third Party free of any obligation of confidence.  A disclosure of Confidential Information (a) in response to a valid order by a court or other governmental body, (b) otherwise required by law, or (c) necessary to establish the rights of either Party under this Agreement, shall not be considered to be a breach of this Agreement or a waiver of confidentiality for other purposes; provided, however, that Recipient shall provide prompt written notice thereof to enable Discloser to seek a protective order or otherwise prevent such disclosure.

4. Use of Confidential Information.  The Parties anticipate exchanging certain technical and business information for the limited purpose of engaging in business discussions relating to the evaluation of technologies, potential business relationship between the Parties and the sale and/or license of patents, patent applications, or inventions by KAIST. Recipient agrees to use any Confidential Information disclosed by Discloser solely for this stated purposes and not for any other purpose.  The Recipient shall not reverse engineer, disassemble or decompile any products, prototypes, software or other tangible objects which embody the Confidential Information disclosed by the Discloser and which are provided to the Recipient.

5. Term.   This Agreement shall be effective from the Effective Date and shall continue for a period of three(3) years.  Either Party may terminate this Agreement without cause upon thirty (30) days advance written notice to the other Party.Each Party's obligations under Paragraph 2 with respect to Confidential Information of the other Party shall continue for five (5) years from the expiration or termination of this Agreement.

6. Return of Information.   All Discloser Confidential Information, copies and summaries thereof shall be returned by the Recipient to the Discloser within thirty (30) days of Discloser's request Or at Discloser's option, Confidential Information, including all copies, may instead be destroyed by Recipient and upon request the Recipient shall certify such destruction in writing to Discloser within five (5) days of Discloser’s instructions to Recipient.

7. NoAssignment.  Neither Party will assign or transfer any rights or obligations under this Agreement without the prior written consent of the other Party.

8. No Title, License, No Warranty.  Title and right to possess Confidential Information shall remain with the Disclosing Party orits Affiliates. No License is granted to either Party under any patents, copyrights, mask work rights, trademarks or other intellectual or proprietary rights of the other. All information provided herein is “AS IS” and without warranty (express or implied) including without limitation any warranty of merchantability, title, fitness for a particular purpose or non-infringement.

9. Governing Law.  This Agreement will be governed by the laws of the Republic of Korea, without giving effect to its conflicts of law principles. With the exception of Section 11, any dispute, controversy or difference which may arise and cannot be amicable settled between the Parties hereto out of or in relation to or in connection with this Agreementshall be submitted to a courtof the Republic of Korea.

10. Waiver.   The waiver by either Party of a breach of any provision hereof shall not be taken or held to be a waiver of the provision itself. Any waiver must be in writing.  Failure by either Party to insist upon strict adherence to any provision of this Agreement on one or more occasions will not deprive such Party of the right to insist upon strict adherence to that or any other provision of this Agreement.

11. Injunctive Relief.   A breach of any of the promises or agreements contained herein will result in irreparable and continuing damage to the non-breaching Party for which there will be no adequate remedy at law, and the non-breaching Party shall be entitled to seek injunctive relief and/or a decree for specific performance, and such other relief as may be proper (including monetary damages if appropriate) in any court of competent jurisdiction.

12. Entire Agreement.  This Agreement states the entire agreement of the Parties regarding its subject matter.  It supersedes, and its terms govern, all prior proposals, agreements, or other communications between the Parties, oral or written, regarding such subject matter. This Agreement shall not be modified except by a subsequently dated written amendment signed on behalf of the Parties.

13. Severability.    If any provision of this Agreement should be held to be invalid in any way or unenforceable, it shall be severed and the remaining provisions shall not in any way be affected or impaired.  This Agreement shall be construed so as to most nearly give effect to the intent of the Parties as originally executed.

14. Binding Effect.   This Agreement will be binding on the respective successors and assigns of the Parties hereto.

15. Export.   The Parties will comply with all applicable laws, rules and regulations relating to the export or re-export of Confidential Information, and will not export or re-export Confidential Information, or the direct product thereof, in violation of applicable laws, rules or regulations.

16. Counterparts.  This Agreement may be executed in counterparts, each of which shall be deemed an original Agreement for all purposes and which collectively shall constitute one and the same Agreement.  A facsimile,PDF or other electronic copy of any such executed counterpart shall be deemed an executed original.

The authorized representatives of the Parties have executed this Agreement as of the last date indicated below (the “Effective Date”).

KAIST(The Korea Advanced Institute of Science and Technology)

Party:

By:

By:

Name:

Name:

Title:

Date:

Title:

Date: